BioXcel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Operational Highlights

NEXT STORY
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102
PREV STORY
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress

WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that ...

author_avatar
NASDAQ Market News

Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress

author_avatar
NASDAQ Market News

Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America

author_avatar
NASDAQ Market News